Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cimetidine for herpes zoster

G M Mavligit, M Talpaz

    The New England Journal of Medicine
    |February 2, 1984
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A phase I, open-label, dose-escalation, multicenter study of the JAK2 inhibitor NS-018 in patients with myelofibrosis.

    Leukemia·2016
    Same author

    Chronic Myeloid Leukemia: Current Guidelines for Diagnosis and Management.

    Hematology (Amsterdam, Netherlands)·2016
    Same author

    A phase 2 randomized dose-ranging study of the JAK2-selective inhibitor fedratinib (SAR302503) in patients with myelofibrosis.

    Blood cancer journal·2015
    Same author

    A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias.

    The New England journal of medicine·2013
    Same author

    Re-emergence of interferon-α in the treatment of chronic myeloid leukemia.

    Leukemia·2012
    Same author

    MK-0457, an Aurora kinase and BCR-ABL inhibitor, is active in patients with BCR-ABL T315I leukemia.

    Leukemia·2012